BS-027125

N/A

Report date: 2025/01/26 18:26:58

Base Information

Drug NameBS-027125

Drug Alias Nameactivated Factor VIII-mimetic bispecific antibody (Bioverativ)FVIIIa mimetic bispecific antibody (Bioverativ)BS-027125

ClassificationBiologics > Protein drugs > Recombinant proteinBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionCoagulation factor VIII stimulants

TargetsCoagulation factor VIII

Therapy Area/IndicationsHemophilia A

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesBioverativ Inc

China Registration ClassN/A

Develop Information

Active CompaniesBioverativ Inc

Inactive CompaniesN/A

Active IndicationsHemophilia A

Inactive IndicationsN/A

Other Information

ATC CodeN/A